insights_auto
Why is RCEL down 3.52%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$15.63
arrow_downward
-3.52%(-0.57) 1D
$15.63
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$16.11
High
$16.11
Low
$15.32
Mkt. cap
491.10M
Avg. vol.
505.08K
Volume
497.28K
52-wk high
$18.43
52-wk low
$3.22
EPS
-$1.18
Beta
2.04
Shares outstanding
31.42M
No. of employees
226
Open
$16.11
High
$16.11
Low
$15.32
Mkt. cap
491.10M
Avg. vol.
505.08K
Volume
497.28K
52-wk high
$18.43
52-wk low
$3.22
EPS
-$1.18
Beta
2.04
Shares outstanding
31.42M
No. of employees
226
News stories
From web sources and news partners
Investing.com
·
10 hours ago
Avita Medical reports warrant exercises by Perceptive and OrbiMed investors By Investing.com
Investing.com India
·
10 hours ago
Form 8K Avita Medical Ltd For: 13 November By Investing.com
Investing.com
·
1 day ago
TD Cowen raises Avita Medical stock price target on growth outlook
GuruFocus
·
1 day ago
RCEL Maintained by TD Cowen -- Price Target Raised to $22.00
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteavitamedical.com